Skip to main content

Mark your calendars for 3 – 5 May 2024, as skin cancer professionals from across Australia and New Zealand come together to Engage and Elevate!

Whether you are an experienced practitioner or new to skin cancer medicine, the 2024 program offers opportunities to engage and elevate your skills across a range of interest areas.

Don’t miss this exciting opportunity to uncover the latest developments in skin cancer diagnosis and treatment. The 2024 Australasian Skin Cancer Congress will once again serve as a valuable platform to network with peers, gain insights from distinguished speakers, and discover the offerings our sponsors bring to enhance your practice. 

Registration

Meet our Speakers

Program Timings

Venue & Accommodation

2024 Sponsors

Featured Speakers

A/Prof Chris Barnes

MBBS, FRACP, FRCPA

Associate Professor Chris Barnes serves as the National Director of Clinical Pathology at Australian Clinical Labs, offering strategic guidance on a national scale for all clinical pathology services. With a background as a clinical and laboratory-trained haematologist and holding a Masters of Business Administration, he brings over two decades of leadership experience in both public and private pathology settings.

Dr Luke Bookallil

MBBS (Syd), MSpMed (UNSW), DCH, DRANZCOG, FARGP, FRACGP, FSCCA

Dr Luke graduated from Sydney University in 1995, and previously practised the full gamut of rural general practice in Armidale NSW, including skin cancer medicine, visiting medical officer appointments and school doctor, making him one of Australia’s most experienced GP’s. He holds a Master of Sports Medicine and a Fellowship in Skin Cancer Medicine. He was awarded the prize for top mark in the SCCA Final Fellowship exam in 2016. He co-established possibly the first Australian school wide based, computer assisted neurocognitive pre- and post-concussion assessment program at The Armidale School. Dr Luke primarily works as a GP specialising in Skin Cancer Medicine in regional NSW and Sydney, but also has several other interests including the gut microbiome. Dr Luke is actively engaged in presenting and teaching for Skin Cancer College Australasia across dermoscopy and surgery, as well as other bodies. He thoroughly enjoys teaching, meeting and learning from colleagues. He is an Adjunct Senior Lecturer at the University of New England and has lectured for both UNE and the University of Newcastle. He is currently involved in skin cancer medicine research and is published in journals. He has recently commenced as Medical Director for Sundoctors Skin Cancer Clinics.

Jennifer Byrne

Jennifer is the current president of the Australian Society of Dermal Clinicians and the Clinical Coordinator for dermal science in the College of Health & Biomedicine at Victoria University (Melbourne). Jennifer was a lecturer for 16 years with a focus on the clinical and interdisciplinary approach to Dermal Therapy. Expertise includes clinical governance, standardising practice, Skin integrity and health, wound/scar and oedema management associated with ageing, chronic health problems and disease. Jennifer also undertakes consultancy work in the areas of education and benchmarking, working with TEQSA as an expert advisor since 2016 in the review and accreditation of dermal therapy and cosmetic medicine/dermatology programs.

A/Prof Sydney Ch'ng

MBBS, PhD, FRACS

A/Prof Sydney Ch’ng is a Head & Neck and Plastic & Reconstructive Surgeon at Melanoma Institute Australia (MIA), Chris O’Brien Lifehouse Cancer Centre and Royal Prince Alfred Hospital (RPA). She is Associate Professor of Surgery at University of Sydney, and Academic Head for Plastic Surgery at RPA. She currently chairs the Education Committees at MIA and the Australian Society of Plastic Surgeons.
During her surgical training, she participated in the surgeon-scientist training pathway, and was awarded a PhD in Tumour Biology in Head Neck Cutaneous Squamous Cell Carcinoma.
Post-FRACS, she undertook almost 3 additional years of fellowship training in head and neck ablative and reconstructive surgery (Sydney Head & Neck Cancer Institute, NSW), advanced oncological reconstructive surgery (MD Anderson Cancer Center, Houston, TX) and adult craniofacial surgery (Chang Gung Memorial Hospital, Taiwan).
Her busy fully-integrated clinical and academic practice focuses on melanoma, non-melanoma skin cancers, parotid surgery, microsurgery, facial symmetrisation (including for facial palsy) and rejuvenation.
She prides herself on delivering evidence-based and patient-centred care where clinical, cosmetic and functional outcomes are optimised. She has published >100 papers in peer-reviewed journals and 15 book chapters. She is an examiner for the Royal Australasian College of Surgeons.

Prof Anne Cust

PhD, MPH(Hons), BSc, BA

Professor Anne Cust is a cancer epidemiologist and NHMRC Investigator Fellow who leads the Melanoma and Skin Cancer stream. Professor Cust’s research has a strong emphasis on translational outcomes that impact policy and clinical practice. She is also a Faculty member of the Melanoma Institute Australia, where she co-leads the ‘Prevention, risk and clinical detection of melanoma’ research theme. Professor Cust leads several large multidisciplinary research programs related to skin cancer prevention, screening and surveillance, and genomic risk of cancer, and is an investigator on international melanoma consortia. She contributes to updating national clinical practice guidelines for melanoma and skin cancer. Professor Cust has over 230 publications and has attracted over $50 million in collaborative grants. In 2018, Professor Cust received the NSW Premier’s Award for Outstanding Cancer Research Fellow of the Year, and in 2015 she was awarded the inaugural Sax Institute Research Action Award for translation of research into health policy. She chairs the Cancer Council National Skin Cancer Committee and NSW Skin Cancer Prevention Advisory Committee. She is a Past President of the Australasian Epidemiological Association (AEA), and has served on the COSA Epidemiology Group Executive, Melanoma and Skin Cancer (MASC) Trials Group Board and on the Scientific Committee for the PC4 Primary Care Collaborative Cancer Clinical Trials Group.

Dr Mohamed Elsaid

MBBcH, MRCS, FSCCA

Dr Elsaid is the principal of OceanMed Skin Cancer Clinic and is a highly experienced Skin Cancer Doctor. After graduating from medical school in Egypt, he obtained his postgraduate Basic Surgical Training (BST) in the UK which was concluded with passing the college exams and being admitted as a Member of the Royal College of Surgeons of Glasgow (MRCS).

In Australia, Dr Elsaid developed a keen interest in Skin Cancer medicine and surgery, and moved on to obtaining a Fellowship in the field with the Skin Cancer College Australasia. Dr Elsaid works extensively in skin cancer of the Head and Neck including Scalp, Ears, Nose, Lips and Eyelid reconstructive surgeries.

Dr Jeremy Hay

MbChB, BMedSci (Dist), FSCCA

Jeremy trained at Otago Medical School. After spells in the NZ and UK hospital system he undertook GP training and then worked for 10 years as a rural GP in Otago. His interest in skin cancer developed during this period and he undertook advanced certificate training courses to advance his skills. In 2014 he moved to Melbourne with his family. One of the specific aims of this move was to allow him to work full time in primary care skin cancer and to attain the Fellowship of the Skin Cancer College of Australasia. These goals were achieved, and Jeremy has worked exclusively in skin cancer medicine since 2015 and was awarded the FSCCA in 2017. He has been an editor of the SCCA educational blog since 2016 and is actively involved in teaching and course development with the College.

Simone Hurley

Simone Hurley is a Narungga / Ngarrindjeri woman living and working on Kaurna Country in South Australia. Simone has worked within the Aboriginal health field for 16 years and is the Cultural Safety Coordinator at The Australian Indigenous Doctors’ Association.

Prof Monika Janda

PhD

Professor Monika Janda is the Director, Centre for Health Services Research, and Professor in Behavioural Science, at the Faculty of Medicine, University of Queensland, and a recent NHMRC Translational Research Fellow (2018-20). Professor Janda leads the NHMRC Centre for Research Excellence in Skin Imaging and Precision Diagnosis (2021-2025) and a NHMRC funded Synergy Program of Research (2022-2026).

She is a health psychologist with a research background in cancer prevention and quality of life research, with strong clinical collaborations, and a passion for consumer-centred digital interventions that make self-management of health-related issues easier and better for people. Her work focuses on applied health and clinical research problems, making a difference to cancer prevention, early detection and treatment outcomes.

Dr Richard Johns

MBBS, FRACGP, FSCCA, GAICD

Following a two decade career as a GP and director of a group General Practice, in the early 2000’s Dr Richard Johns developed an interest in skin cancer medicine and subsequently participated in, co-organised and lectured at skin cancer conferences and workshops in Australia and overseas.
He was the 2012 Founding President of the Skin Cancer College Australasia (SCCA), and obtained SCCA Fellowship, achieved Graduate status of the Australian Institute of Company Directors, and continued as a Director of SCCA until 2021. He has served on various SCCA committees, was a blog author for several years and is now a SCCA Life Fellow.
He has presented lectures at SCCA Conferences, Symposiums, RACGP Updates, SCCA Advanced Surgical Workshops and the World Congress of Dermoscopy.
He has contributed to research in association with the QIMR Berghofer Medical Research Unit and authored the “SCAN Your Skin” early detection programme.
He owns and manages a skin cancer clinic in the western suburbs of Brisbane and has a special interest in skin surgery, photodynamic therapy, and photography.

Dr Dan Kennedy

MBBS, FRACS (Plast)

Dr Dan Kennedy attended Medical School at the University of Queensland completing his MBBS in 1984.
He did his internship and Junior House Officer jobs at Princess Alexandra Hospital before spending a year as a Senior House Officer at the Frenchay Plastic Surgery Unit in Bristol, UK. He returned to Australia performing a year of General Surgery before beginning advanced training in plastic Surgery at Princess Alexandra Hospital, Royal Brisbane Hospital and Royal Children’s Hospital.
Dr Kennedy finished his training with a year in London at Mount Vernon. Acting as a senior Registrar in a busy plastic surgical unit he covered the full gamut of plastic surgery procedures but specially focussed on facial reanimation surgery.
Dr Kennedy runs the Pacific Day Surgery Unit in Fortitude Valley, Brisbane, and has his own private practice. He is a keen advocate of the ACRRM Tele-Derm service and values the opportunity to assist Rural Generalists by sharing his expertise and providing advice. With a special interest in facial plastic surgery including skin cancers, Dr Kennedy plays an integral role in the Tele-Derm team, helping to tackle Australia's skin cancer rate which ranks highest in the world. Using his knowledge and skillset, Dr Kennedy supports practitioners in rural and remote areas, with a particular focus on skin cancer management.
Dr Kennedy is an examiner in the Fellowship exam in Plastic and Reconstructive Surgery.
Memberships include ASPS, ASAPS, ISAPS, AMA, RACS, PRSSQ and American Society of Plastic Surgeons.

A/Prof Victoria Mar

MBBS (Hons), FACD, PhD

A/Prof Victoria Mar is a Fellow of the Australian College of Dermatologists. She trained in Melbourne at the Alfred, Austin and Royal Melbourne Hospitals and at St George’s Hospital, London. She completed her PhD through Monash University at the Alfred Hospital and Peter McCallum Cancer Institute, investigating the clinical and molecular characteristics of nodular melanoma.
Victoria is the Director of the Victorian Melanoma Service at The Alfred and Adjunct Associate Professor at the School of Public Health and Preventive Medicine, Monash University. She has a keen interest in early detection and prevention of both melanoma and non-melanoma skin cancer. She is a board member of the Melanoma and Skin Cancer Trials Group.
She has co-authored a number of chapters for the Cancer Council Australia Melanoma Guidelines and is Clinical Lead for the Melanoma Clinical Outcomes Registry and Victorian Lead for the Australian Centre of Excellence for Melanoma Imaging and Diagnosis.

Dr. Ash Marghoob

MD, SUNY at Stony Brook

Dr Marghoob is a board-certified dermatologist specializing in the diagnosis and treatment of cancers of the skin. He is the director of Memorial Sloan Kettering’s regional skin cancer clinic in Hauppauge, Long Island. In addition to consulting and treating patients in Hauppauge, he also sees patients at the Centre’s outpatient facility in Manhattan.

Providing the best care possible for his patients is his primary goal, but he remains committed to education and clinical research. His hope is that educating physicians and the public about the importance of early skin cancer detection will help save lives.

He is active in clinical research and has published numerous papers on topics related to skin cancer with an emphasis on melanoma, atypical/dysplastic naevi, and congenital melanocytic naevi. His research interests are focused on the use of imaging instruments such as photography, dermoscopy, and confocal laser microscopy to recognize skin cancer early in its development. He frequently lectures on these topics both nationally and internationally.

A/Prof Jim Muir

MBBS, FACD

A/Prof Jim Muir is a dermatologist in the private, public and virtual practice.
Besides practicing at South East Dermatology he is the Director of the Department of Dermatology at the Mater Hospital, South Brisbane. As the dermatologist for ‘Telederm National’, a website run by the Australian College of Rural and Remote Medicine, Jim also delivers dermatological care to all parts of Australia via the internet. He regularly lectures on dermatology to other specialists, general practitioners, medical students, pharmacists and the general public. Jim is also a senior lecturer in dermatology at the University of Queensland, a moderator of the International Dermoscopy Society and Chair of the Brisbane Hospitals Dermatology Group.
He is a founder of the Australian Skin Cancer Academy and has well over 60 publications including book chapters. Jim's areas of interest include early diagnosis, neoplastic skin disease, skin disease in the elderly, medical education, critical analysis of published research and medicolegal issues.

Prof Rachel Neale

BVSc, PhD

Professor Rachel Neale completed a Bachelor of Veterinary Science at the University of Queensland and spent a short time in clinical practice, before deciding that her heart lay in science and research. She completed a PhD in skin cancer prevention at the QIMR Berghofer. Professor Neale then obtained an NHMRC Sidney Sax Fellowship which enabled her to spend two years at the University of Oxford. This enabled her to play a vital role in an international consortium studying the effects of human papilloma virus on the development of cutaneous squamous cell carcinoma.
Upon returning to Australia, Professor Neale established a program of research into pancreatic cancer, and later into vitamin D. In light of her knowledge of both skin cancer and vitamin D she is able to contribute to policy discussions about balancing the risks and benefits of sun exposure; she leads the health working group for the United Nations Environmental Effects Assessment Panel which reports to the parties to the Montreal Protocol. Professor Neale is the deputy coordinator of the population health department and holds adjunct appointments at the Queensland University of Technology and University of Queensland.

Gae Nuttall

Gae Nuttall is a Risk Adviser at MDA National, joining the organisation in May 2015. Gae’s professional interests include medico-legal education, practice management and accreditation systems. She believes that implementing good practice systems minimises risk to both doctors and their practice staff, while providing quality health care. Gae is a Registered Nurse, with extensive experience in GP education and orientation of doctors new to the Australian health care system.
As part of MDA National’s Support in Practice team Gae provides practical assistance and advice to medical practitioners and practice managers to help reduce their medico-legal risk.
Previous external conference presentations include AMA Business Owners Victoria, QLD and NSW; RACGP WA Practice Owners and general member sessions; and AMA WA general member and practice manager sessions.

Prof Cliff Rosendahl

MBBS, PhD

Cliff Rosendahl is a GP of over 45 years’ experience, with a background in rural general practice and forensic medicine. His PhD project was in the field of skin cancer, particularly melanoma.
Cliff is a Professor at The University of Queensland, Australia, where he is a course coordinator in the Skin Cancer Program and he is a Visting Professor at Tehran University of Medical Sciences, Iran. He has published over 100 papers in peer-review journals and has co-authored 2 textbooks on dermatoscopy, which have been published in 9 and 4 languages respectively.
Cliff enjoys speaking to GP groups in Australia and GPs and dermatologists internationally.

Dr Helena Rosengren

MBChB, FRACGP, FACSM, FSCCA, MMed, MPHTM, DRCOG

With over two decades experience in skin cancer medicine and an SCCA fellowship, Dr Helena Rosengren is the medical director of a large stand-alone skin cancer practice in Townsville that she founded in 2009.

A diligent supporter of SCCA, Helena holds a board position and is a member of the newly formed Academic Council. In a quest to help reduce skin cancer morbidity and mortality, Helena is actively engaged in organising community initiatives and had a seat on the working party that developed the Keratinocyte Cancer Guidelines for Australia published in 2019.

Passionate about teaching, Helena enjoys giving skin cancer lectures in Australia and overseas. She has been a senior lecturer at James Cook University for over 15 years and has been delighted to introduce dermoscopy to the JCU medical student curriculum. With a keen interest in research, she has published a number of skin cancer research papers and was the chair of the research committee for SCCA for a number of years.

Prof Ruth Salom

FRCPA, MD, MBBS, BMedsci (Hon), MBA, FAICD

A graduate from Monash University, Professor Ruth Salom completed her Fellowship in 1996 already having a strong interest in skin pathology. Prior to entering dermatopathology training, Ruth completed a 12-month skin cancer research project in the Department of Dermatology at Monash University. She received additional training in dermatopathology working with the late Dr Abe Dorevitch in Melbourne and Professor A. Bernard Ackerman at his Institute for Dermatopathology in Philadelphia.

Ruth was an invited author for the WHO Classification of Tumours publication on the Pathology and Genetics of Skin Tumours (2003). Whilst working in management, research and academia she has practiced as a specialist Dermatopathologist since 1996. Over the years Ruth has participated as a speaker at local, national and international conferences. Ruth understands clinical practice and the challenges of uncertainty, having practiced clinically herself. Ruth is a regular tutor for the Dermatopathology for Skin Cancer Clinicians course run by Skin Cancer College Australasia.

prof-peter-soyer

Prof Peter Soyer

MD, FACD, FAHMS

Inaugural Chair in Dermatology at UQ and Director of the Princess Alexandra Hospital Dermatology Department (2008 – 2022). More than 200 publications in the last five years. He initiated and was co-leader of the Australian Skin and Skin Cancer Research Centre, a collaboration between UQ and QIMR Berghofer Medical Research Institute. Co-president of the 9th World Congress of Melanoma in Brisbane 2017. Leading the Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID), a consortium of The Universities of Queensland, The University of Sydney and Monash University. Fellow of the Australian Academy of Health and Medial Sciences.

Dr Ryan Van Laar

PhD

Dr. Ryan Van Laar, with a Ph.D. in bioinformatics and ovarian cancer genomics from the University of Melbourne, has developed a strong career in genomic research, including positions at Agendia, Regeneron Pharmaceuticals, and Signal Genetics, leading to the establishment of Geneseq Biosciences in Melbourne. His work in the development and regulatory approval of advanced oncology diagnostic tests is supported by multiple patents and over 25 peer-reviewed publications. Certified in high-complexity molecular genomic testing by the New York State Department of Health, Dr. Van Laar focuses on enhancing cancer treatment through the integration of technology and the latest in cancer biology.

Dr Ranghu Vasanthan

MBChB, FRACGP, Dip Derm, MMed (Skin Cancer)

Dr Raghu Vasanthan graduated from the University of Auckland in New Zealand in 2008 and attained his fellowship from the Royal Australian College of General Practitioners in 2015. He has a special interest in Dermatology and holds additional qualifications with a Diploma of Dermatology and a Master of Medicine qualification from The University of Queensland focusing on Skin Cancer. He was one of the first GP’s in the country to get formal recognition of his extended skills in Dermatology from the RACGP. (RES-FRACGP) Being passionate about medical education and research, he is undertaking some medical research with Professor Tony Dicker (UQ) and has peer reviewed articles published in medical journals.

Dr Chris Wetherall

MBBS, MMed (Skin Cancer), FRACGP, FSCCA

Dr Chris Wetherall is a passionate medical educator and dermoscopist. He obtained his MBBS and Masters Degree from the University of Queensland. He is a fellow of SCCA and RACGP, and holds a Diploma of Dermatology. Chris works full time as a primary care skin cancer GP in a large multidisciplinary primary care practice. He completed a Graduate Certificate of Medical Education at University of Wollongong in 2016. He is a College Censor, clinical co-ordinator of the SCCA Advanced Clinical Certificate of Dermoscopy, and a Senior Clinical Lecturer with the Universities of QLD and Wollongong.

Woodrow Wilson

Woodrow Wilson founded Clinical Imaging Australia in 2014 - an agency specialised in modernising photography in aesthetic and therapeutic clinics.
Everyday hundreds of patients around the world experience the systems he designed, enabling clinicians to accurate chart patient results, comply with government guidelines and ethically market with standardised objective imaging.

Program Timings

The Australasian Skin Cancer Congress 2024 program will feature a diverse range of engaging speakers. Join us to hear about emerging technologies for melanoma diagnosis, explore histology stains, and examine methods for capturing and managing clinical images.

Stay tuned for the full release of the Australasian Skin Cancer Congress 2024 program coming soon! In the meantime, see below the program timings.

Registration
8.30 – 9.00am

SESSION 1
9.00 – 10.30am

SESSION 2
11.00am – 12.30pm

SESSION 3
1.30 – 3.00pm

SESSION 4
3.30 – 5.00pm

Welcome Drinks
5.00 – 7.00pm

SESSION 5
9.00 – 10.30am

SESSION 6
11.00am – 12.30pm

SESSION 7
1.30 – 3.00pm

SESSION 8
3.30 – 5.00pm

SCCA General Meeting (Members only)
5.00 – 6.00pm

SESSION 9
9.00 -10.30am

SESSION 10
11.00am – 12.30pm

Takeaway Lunch
12.30 – 1.00pm

Program is subject to change. It is not guaranteed all sessions will be available on demand.
We recommend attending sessions live for the best experience.

Thank you to our Sponsors

Make sure you save time to explore the Exhibition Hall in person at the Australasian Skin Cancer Congress 2024!

Platinum Sponsor

Gold Sponsor

Bronze Sponsor